Nakamoto Inc.

NASDAQ:NAKA

Financial - Capital Markets

Financial Services
$4.45 +0.03%

+$0.00 today

Market cap
$77.44M
Beta
-0.90
P/E (TTM)
-0.2
EPS (TTM)
-$18.22
52W Low $4.05High $679.20

Volume 0.13M

Average 0.24M

NAKA EBITDA Margin

EBITDA as a percentage of revenue.

Nakamoto Inc.NASDAQ: NAKA

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to -8717.0%

EBITDA Margin was -8717.0% in Q1 FY2026, down 8542.2 pp from a year earlier. On a trailing-twelve-month basis it was -7060.9%, down 6900.9 pp year over year. Over 3 fiscal years it narrowed by 2402.8 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 2 analysts of -130.2% for the fiscal year ending Dec 2026, up from -2466.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-8717.0%-18684.8 pp QoQ
Last fiscal yearDec 2025
-2466.7%-2356.3 pp YoY
LTMMar 2026
-7060.9%-6900.9 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8542.2 pp+504.3 pp+9046.5 pp
1 year-2356.3 pp+2336.5 pp+4692.7 pp
3 years-2402.8 pp+2462.5 pp+4865.3 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-2466.7%
Year-over-year change
-2356.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How NAKA compares with its peers on the latest reported figures

  • NAKA's LTM Mar 2026 EBITDA Margin of -7060.9% is the 8th highest of the 9 companies compared; the peer median is -4.1%.
  • Its year-over-year change of -6900.9 pp is the 8th highest of 9, against a peer median of -0.9 pp.
  • Over three fiscal years its change of -2402.8 pp compares with a peer median of +4.3 pp.
NAKA Competitors Peer median
EBITDA Margin for NAKA and competitors
Company Period LTM level YoY 3-year change
SLPSimulations Plus, Inc.LTM Feb 202621.5% +0.4 pp-16.1 pp
DHDefinitive Healthcare Corp.LTM Mar 20264.9% +295.3 pp-78.9 pp
DCTHDelcath Systems, Inc.LTM Mar 20261.8% +1.6 pp+1243.6 pp
AMRNAmarin Corporation plcLTM Mar 2026-2.4% +29.0 pp+11.8 pp
AGLAgilon Health, Inc.LTM Mar 2026-5.9% -2.2 pp-3.2 pp
CLLSCellectis S.A.LTM Mar 2026-75.1% -6.9 pp+343.8 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-81.4% -6.3 pp+87.8 pp
NAKANakamoto Inc.LTM Mar 2026-7060.9% -6900.9 pp-2402.8 pp
LYELLyell Immunopharma, Inc.LTM Mar 2026-770932.3% -482924.6 pp-730107.8 pp
LRMRLarimar Therapeutics, Inc.FY2025— ——
DBVTDBV Technologies S.A.FY2025— ——
Peer median (excluding NAKA) -4.1%-0.9 pp+4.3 pp

Competitors are the stored peer set for NAKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.5M3.79M3.77M2.72M1.82M
Cost of Revenue1.59M152.39K226.17K3.56M11.09M
Gross Profit914.92K3.63M3.54M(842.57K)(9.27M)
Gross Margin36.5%96.0%94.0%-31.0%-508.8%
Research & Development002.5K377.73K0
Selling, General & Admin853.58K6.27M5.05M1.91M11.76M
Operating Expenses853.58K6.33M5.16M2.5M187.87M
Depreciation & Amortization63.4K122.01K203.22K220.33K241.99K
EBITDA124.74K(2.42M)(1.36M)(3M)(44.93M)
EBITDA Margin5.0%-63.9%-36.0%-110.4%-2466.7%
Operating Income61.34K(2.69M)(1.62M)(3.35M)(197.14M)
Operating Margin2.4%-71.1%-43.0%-123.1%-10824.0%
Interest Income00000
Interest Expense0055.84K393.45K7.06M
Other Income / Expenses88K152.82K2.76K(270.88K)144.91M
Income Before Tax149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Pre-Tax Margin6.0%-67.1%-42.9%-133.0%-2867.6%
Income Tax Expense00000
Net Income149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Net Margin6.0%-67.1%-42.9%-133.0%-2867.6%
EPS (Basic)0.03(0.43)(0.27)(0.67)(10.40)
EPS (Diluted)0.03(0.43)(0.27)(0.67)(10.40)
Weighted Avg Shares5.97M5.89M5.89M5.39M11.36M
Weighted Avg Shares (Diluted)5.97M5.89M5.89M5.39M11.36M

Nakamoto Inc.

NASDAQ:NAKA

Intrinsic Alpha fair value

Locked

Current Price

$4.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.